Magnetic resonance spectroscopy in differential diagnosis of benign and malignant meningiomas

Chinese Journal of Medical Imaging Technology

Volumn 22, Issue 5, 2006, Pages 674-677

  Shi, Rui Hua ^a   Zhai, Ren You ^a   Qian, Xiao Jun ^a   Pan, Zhen Yu ^a   Ding, Yi ^a   Lu, Wan Hong ^a   Meng, Zhao Quan ^a   Zhou, Yi Ming ^a   Bao, Na ^a   Gu, Hua ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Differential diagnosis; Magnetic resonance spectroscopy; Meningiomas

Indexed keywords

CARBENE; CHOLINE; CREATININE; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; MALIGNANT MENINGIOMA; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGICAL PROCEDURES; SCHOOL CHILD; STATISTICAL SIGNIFICANCE;

EID: 33744974112     PISSN: 10033289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Chamberlain MC. Intracerebral meningiomas [J]. Curr Treat Options Neurol, 2004,6(4):297-305.
2. Servo A, Porras M, Jaaskelainen J, et al. Computed tomography and angiography do not reliably discriminate malignant meningiomas from benign ones[J]. Neuroradiology, 1990,32(2):94-97.
3. Fountas KN. In vivo proton magnetic resonance spectroscopy of brain tumors[J]. Stereotact Funct Neurosurg, 2000,74(2):83-94.
4. Shimizu H, Kumabe T, Shirane R, et al. Correlation between Choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas[J]. AJNR, 2000,21(4):659-665.
5. Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy [J]. NMR Biomed, 1997,10(1):2-12.
6. Manton DJ, Lowry M, Blackband SJ, et al. Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumors [J]. NMR Biomed, 1995, 8 (3):104-112.
7. Shiino A, Nakasu S, Matsuda M, et al. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy [J]. J Neurosurg, 1999,91(6):928-934.
8. 1H-MRS) in vitro[J]. Acta Neurochir Suppl, 2000,76(1):17-20.
9. Burtscher IM, Holtas S. Proton MR spectroscopy in clinical routine [J]. J Magn Reson Imaging, 2001,13(2):560-567.
10. 1H MRS [J]. Magn Reson Med, 2003,49(4):632-637.
11. Domigo Z, Rowe G, Blamine AM. Role of ischemic in the genesis of edema surrounding meningomas assessed using magnetic resonance imaging and spectroscopy [J]. Br J Neurosurg, 1998, 12 (5):414-418.
12. 1H magnetic resonance spectroscopy[J]. Magn Reson Med, 2003,49(2):223-232.
13. Bitzer M, Klose U, Geist-Barth B, et al. Alterations in diffusion and perfusion in the pathogenesis of peritumoral brain edema in meningiomas[J]. Eur Radio J, 2002,12(8):2062-2076.
14. Uematsu H, Maeda M, Itoh H. Peritumoral brain edema in intracranial meningiomas evaluated by dynamic perfusion-weighted MR imaging: a preliminary study [J]. Eur Radiol, 2003, 13 (4): 758-762.
15. 1H MRS in the diagnosis of brain tumor[J]. Chin J Med Imaging Technol, 2003,19(9):1243-1246.